Cardeas Pharma's Series B - II Round

Cardeas Pharma raised a round of funding on April 09, 2015.

Cardeas is a privately held biopharmaceutical company dedicated to the development and commercialization of inhaled antibiotics to treat serious, hospital-acquired respiratory infections with highly a…

Articles about Cardeas Pharma's Series B - II Round: